Related Experiment Video

Updated: Jul 6, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Depression, antidepressants and heart disease

    Drug and Therapeutics Bulletin
    |April 12, 2008
    PubMed

    Insights

    Major depression affects 1 in 5 coronary artery disease patients, worsening heart disease prognosis. This review examines antidepressant effects on heart health and cardiac outcomes in these patients.

    Area of Science:

    • Cardiology
    • Psychiatry
    • Pharmacology

    Background:

    • Major depression is prevalent in coronary artery disease (CAD) patients.
    • Depression negatively impacts cardiovascular prognosis.
    • Antidepressants may have cardiovascular side effects, complicating treatment choices.

    Purpose of the Study:

    • To evaluate the cardiovascular safety of commonly used antidepressants in CAD patients.
    • To determine if antidepressants exacerbate heart disease.
    • To assess the impact of depression treatment on cardiac outcomes.

    Main Methods:

    • Literature review of studies on antidepressants and cardiovascular effects.
    • Analysis of clinical trial data and observational studies.
    • Examination of pharmacological profiles of antidepressants regarding cardiac function.

    Main Results:

    • Certain antidepressants may pose higher cardiovascular risks than others.
    • Evidence suggests a potential benefit of treating depression on cardiac outcomes.
    • Further research is needed to establish definitive guidelines.

    Conclusions:

    • Careful selection of antidepressants is crucial for CAD patients with depression.
    • Treating depression may improve cardiovascular prognosis.
    • Personalized treatment strategies are recommended.

    More Related Videos

    An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents06:55

    An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

    Published on: December 2, 2015

    Related Concept Videos

    Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

    Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

    Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
    Antidepressant Drugs: MAOIs and Other Agents01:23

    Antidepressant Drugs: MAOIs and Other Agents

    Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
    Antidepressant Drugs: Overview01:25

    Antidepressant Drugs: Overview

    Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
    Depression: Overview01:18

    Depression: Overview

    Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Drug Therapy01:28

    Drug Therapy

    The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
    Antianxiety Medications